Abstract:Two CD33 common variants, rs3826656 and rs3865444, have been identified to be correlated with Alzheimer's disease (AD). Our study examined the effects of the two AD-related CD33 common variants (rs3826656 and rs3865444) on the chosen AD-related brain regions (including hippocampus, amygdala, parahippocampus, middle temporal, entorhinal cortex, and total brain volume) in non-demented elders recruited from the Alzheimer's Disease Neuroimaging Initiative database at baseline and during four-year follow-up. We further tested the effects in an A beta-positive group (including preclinical and prodromal stage of AD) and an A beta-negative group. In the total non-demented elderly population, no associations reached significant levels after FDR correction. In the A beta-positive group, we found that rs3826656 was associated with hippocampal and amygdala volumes (Hippocampus-R: p(c) = 0.0022; Amygdala-L: p(c) = 0.0044; Amygdala-R: p(c) = 0.0066), and rs3865444 was associated with right entorhinal volume (p(c) = 0.0286). The associations of rs3826656 with hippocampal and amygdala volumes in the A beta-positive group were successfully replicated in the prodromal AD group (Hippocampus-R: p(c) = 0.0022; Amygdala-L: p(c) = 0.0022; Amygdala-R: p(c) = 0.0088). These changes became more obvious over time during four-year follow-up. No associations were found between the two CD33 variants and neuroimaging biomarkers in the A beta negative and preclinical AD groups after FDR correction. These results suggested that the two CD33 common variants (rs3826656 and rs3865444) influenced volumes and atrophy rates of AD-related brain regions in non-demented elders. Subgroup analyses showed the effects mainly existed in the A beta-positive group instead of the A beta-negative group, and the effects began in the prodromal AD stage.

Common Variant in PLD3 Influencing Cerebrospinal Fluid Total Tau Levels and Hippocampal Volumes in Mild Cognitive Impairment Patients from the ADNI Cohort

Genetic Variants of PICALM Rs541458 Modulate Brain Spontaneous Activity in Older Adults with Amnestic Mild Cognitive Impairment

Impact of Common Variations in PLD3 on Neuroimaging Phenotypes in Non-demented Elders

Common Variants In Pld3 And Correlation To Amyloid-Related Phenotypes In Alzheimer'S Disease

Rare Variants in PLD3 Increase Risk for Alzheimer's Disease in Han Chinese.

Common Variants in ABI3 Influence Cerebrospinal Fluid Total Tau Levels and Cognitive Decline in Progressive Mild Cognitive Impairment Patients.

Common Variants in PLXNA4 and Correlation to CSF-related Phenotypes in Alzheimer's Disease.

PLD3 in Alzheimer’s Disease: a Modest Effect as Revealed by Updated Association and Expression Analyses

PLD3 in Alzheimer’s Disease

Novel Genetic Variants in TP37, PIK3R1, CALM1, and PLCG2 of the Neurotrophin Signaling Pathway Are Associated with the Progression from Mild Cognitive Impairment to Alzheimer's Disease

Association of Cd33 and Ms4a Cluster Variants with Alzheimer'S Disease in East Asian Populations

rs56405341 Variant Associates with Expression of <i>C4orf33</i> and <i>C4orf33</i> Was Downregulated in Alzheimer's Disease and Progressive Supranuclear Palsy

Effects of HLA - DRB1 / DQB1 Genetic Variants on Neuroimaging in Healthy, Mild Cognitive Impairment, and Alzheimer’s Disease Cohorts

Validating Gwas-Identified Risk Loci for Alzheimer'S Disease in Han Chinese Populations

A genome-wide association study of longitudinal change in CSF tau among non-demented elderly

Effects of CD33 Variants on Neuroimaging Biomarkers in Non-Demented Elders.

Genome-wide Association Study of Cerebrospinal Fluid Neurofilament Light Levels in Non-Demented Elders.

Associations Between TREML2 Gene Variants and Alzheimer's Disease: Biomarkers, Neuroimage, and Cognition

Genome-wide Association Study Identifies CBFA2T3 Affecting the Rate of CSF Aβ42 Decline in Non-Demented Elders.

Impacts of CR1 Genetic Variants on Cerebrospinal Fluid and Neuroimaging Biomarkers in Alzheimer’s Disease

PICALM and CR1 variants are not associated with sporadic Alzheimer's disease in Chinese patients.